Addex Therapeutics Ltd (ADXN)
NASDAQ: ADXN · Real-Time Price · USD
6.87
+0.17 (2.54%)
May 13, 2026, 4:00 PM EDT - Market closed
Addex Therapeutics Employees
Addex Therapeutics had 2 employees as of December 31, 2024. The number of employees decreased by 21 or -91.30% compared to the previous year.
Employees
2
Change (1Y)
-21
Growth (1Y)
-91.30%
Revenue / Employee
$109,087
Profits / Employee
-$4,243,017
Market Cap
6.71M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 2 | -21 | -91.30% |
| Dec 31, 2023 | 23 | -1 | -4.17% |
| Dec 31, 2022 | 24 | -2 | -7.69% |
| Dec 31, 2021 | 26 | -1 | -3.70% |
| Dec 31, 2020 | 27 | 8 | 42.11% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| BioAtla | 41 |
| Processa Pharmaceuticals | 12 |
| TransCode Therapeutics | 12 |
| XTL Biopharmaceuticals | 10 |
| Purple Biotech | 10 |
| Immuron | 7 |
| Can-Fite BioPharma | 5 |
| Silo Pharma | 3 |
ADXN News
- 12 days ago - Q4 2025 Addex Therapeutics Ltd Earnings Call Transcript - GuruFocus
- 13 days ago - Addex Therapeutics Earnings Call Transcript: H2 2025 - Transcripts
- 13 days ago - Addex Reports Full Year 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 14 days ago - Addex Therapeutics (ADXN) Reveals Promising Preclinical Results for Chronic Cough Treatment - GuruFocus
- 14 days ago - Addex Therapeutics announces GABAB PAM candidate data - TheFly
- 14 days ago - Addex GABAB PAM Candidate Demonstrates Solid Anti-Tussive Activity in Bleomycin IPF-Related Chronic Cough Model - GlobeNewsWire
- 20 days ago - Addex Therapeutics (ADXN) Sees Progress with Neurosterix's Clinical Study - GuruFocus
- 20 days ago - Addex Therapeutics says spin-out company to complete NTX-253 study in Q2 - TheFly